Xenoestrogen Modulation of the Immune System: Effects of Dichlorodiphenyltrichloroethane (DDT) and 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)

Reviews on Environmental Health

Volumn 19, Issue 1, 2004, Pages 1-13

  Forawi, Hanan A ^a,b   Tchounwou, Paul B ^a   McMurray, Robert W ^a,b,c  

^a Jackson State University   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cytokines; Dioxins; Endocrine disruption; Immunity; Pesticides; Xenoestrogen

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHANE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANTIESTROGEN; ENDOCRINE DISRUPTOR; ESTROGEN AGONIST; ESTROGEN DERIVATIVE; ORGANIC COMPOUND; UNCLASSIFIED DRUG; XENOESTROGEN;

AGRICULTURE; CARCINOGENESIS; DEVELOPMENTAL DISORDER; ENDOCRINE DISEASE; HORMONAL REGULATION; HYPERPLASIA; HYPOPLASIA; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INDUSTRIAL MEDICINE; NONHUMAN; REVIEW; THYMUS ATROPHY; TISSUE SPECIFICITY; WEIGHT REDUCTION;

EID: 2442623313     PISSN: 00487554     EISSN: None     Source Type: Journal    
DOI: 10.1515/reveh.2004.19.1.1     Document Type: Review

References (139)

1. Tapiero H, Ba GN, Tew KD. Estrogens and environmental estrogens. Biomed Pharmacother 2002; 56: 36-44.
2. Wolff MS. Environmental estrogens. Environ Health Perspect 1995; 103: 784-785.
3. Neubert D. Vulnerability of the endocrine system to xenobiotic influence. Reg Toxicol Pharmacol 1997; 26: 9-29.
4. Ahmed SA, Hissong BD, Verthelyi D, Donner K, Becker K, Karpuzoglu-Sahin E. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ Health Perspect 1999; 107: 681-686.
5. Verthelyi D. Sex hormones as immunomodulators in health and disease. Int Immunopharmacol 2001; 1: 983-993.
6. Crinniori WJ. Environmental medicine, part one: the human burden of environmental toxins and their common health effects. Altern Med Rev 2000; 5: 52-63.
7. Safe SH. Endocrine disrupters and human health - is there a problem? An update. Environ Health Perspect 2000; 108(6): 487-493.
8. Ziegler J. Environmental "endocrine disrupters" get a global look. J Natl Cancer Inst 1997; 89: 1184-1187.
9. Sohoni P, Sumpter JP. Several environmental estrogens are also anti-androgens. J Endocrinol 1998; 158: 327-339.
10. Jordan VC, Lieberman ME. Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structure. Mol Pharmacol 1984; 26: 279-285.
11. McMurray RW. Estrogen, prolactin, and autoimmunity. Int Immunopharmacol 2001; 1: 995-1008.
12. Turusov V, Rakitsky V, Tomatis L. Dichlorodiphenyltrichloroethane (DDT): ubiquity, persistence, and risks. Environm Health Perspect; 2002; 110: 125-128.
13. Smith AG. Chlorinated hydrocarbon insecticides. In: Hayes WJ, Laws ER, Eds, Handbook of Pesticides Toxicology. San Diego, New York, USA: Academic Press Inc, 1991; 1-731.
14. World Health Organization (WHO). Safe use of pesticides. WHO Technical Report Series No. 513. Geneva, Switzerland: WHO, 1973.
15. Matthews J, Celius T, Halgren R, Zacharewski T J. Differential estrogen receptor binding of estrogenic Substances: a species comparison. Steroid Biochem Mol Biol 2000; 74: 223-234.
16. Nejaty H, Lacey M, Whitehead SA. Differing effects of endocrine-disrupting chemicals on basal and FSH-stimulated progesterone production in rat granulosa-luteal cells. Exp Biol Med (Maywood) 2001; 226: 570-576.
17. Bradlow HL, Davis DL, Lin G, Sepkovic D, Tiwari R. Effects of pesticides on the ratio of 16 alpha/2-hydroxyestrone: a biologic marker of breast cancer risk. Environ Health Perspect 1995; 103: 147-150.
18. Schmidt JV, Bradfield CA. Ah receptor signaling pathways. Annu Rev Cell Dev Biol 1996; 12: 55-89.
19. Kharat I, Saatcioglu F. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin are mediated by direct transcriptional interference with the liganded estrogen receptor. Cross-talk between aryl hydrocarbon- and estrogen-mediated signaling. J Biol Chem 1996; 271: 10533-10537.
20. Ndebele K, Tchounwou PB, McMurray RW. Effects of xenoestrogens on T lymphocytes: modulation of bcl-2, p53, and apoptosis. Int J Mol Sci 2003; 4: 45-61.
21. Rupa DS, Reddy PP, Sreemannarayana K, Reddi OS. Frequency of sister chromatid exchange in peripheral lymphocytes of male pesticide applicators. Environ Mol Mutagen 1991; 18: 136-138.
22. Rupa DS, Rita P, Reddy PP, Reddi OS. Screening of chromosomal aberrations and sister chromatid exchanges in peripheral lymphocytes of vegetable garden workers. Hum Toxicol 1988; 7: 333-336.
23. Rupa DS, Reddy PP, Reddi OS. Frequencies of chromosomal aberrations in smokers exposed to pesticides in cotton fields. Mutat Res 1989; 222: 37-41.
24. Lessa JM, Becak W, Nazareth Rabello M, Pereira CA, Ungaro MT. Cytogenetic study of DDT on human lymphocytes in vitro. Mutat Res 1976; 40: 131-138.
25. Rabello MN, Dealmeida WF, Pigati P, Ungaro MT, Murata T, Perira CA, Becak W. Cytogenetic study on individuals occupationally exposed to DDT. Mutat Res 1975; 28: 449-454.
26. Lee CH, Edwards AM. Differential expression of c- fos and c- myc protooncogenes by estrogens, xenobiotics and other growth-stimulatory agents in primary rat hepatocytes. Arch Toxicol 2003; 77: 150-159.
27. Dees C, Foster JS, Ahamed S, Wimalasena J. Dietary estrogens stimulate human breast cells to enter the cell cycle. Environ Health Perspect 1997; 105: 633-636.
28. Burow ME, Tang Y, Collins-Burow BM, Krajewski S, Reed JC, McLachlan JA, Beckman BS. Effects of environmental estrogens on tumor necrosis factor alpha-mediated apoptosis in MCF-7 cells. Carcinogenesis 1999; 20: 2057-2061.
29. McCabe M, Yin-Foo D. Effects of DDT on the calcium transport and thymidine uptake of bovine lymphocytes. Bull Environ Contam Toxicol 1986; 37: 523-530.
30. Derfoul A, Lin FJ, Awumey EM, Kolodzeski T, Hall DJ, Tuan RS. Estrogenic endocrine disruptive components interfere with calcium handling and differentiation of human trophoblast cells. J Cell Biochem 2003; 89: 755-770.
31. Shinomiya N, Shinomiya M. Dichlorodiphenyltrichloroethane suppresses neurite outgrowth and induces apoptosis in PC12 pheochromocytoma cells. Toxicol Lett 2003; 137: 175-183.
32. Gilbertson MK, Haffner GD, Drouillard KG, Albert A, Dixon B Immunosuppression in the northern leopard frog (Rana pipiens) induced by pesticide exposure. Environ Toxicol Chem 2003; 22: 101-110.
33. Subba Rao DS, Glick B. Pesticide effects on the immune response and metabolic activity of chicken lymphocytes. Proc Soc Exp Biol Med 1977; 154: 27-29.
34. Latimer JW, Siegel HS. Immune response in broilers fed technical grade DDT. Poult Sci 1974; 53: 1078-1083.
35. Banerjee BD, Koner BC, Ray A. Influence of stress on DDT-induced humoral immune responsiveness in mice. Environ Res 1997; 74: 43-47.
36. Banerjee BD, Ray A, Pasha ST. A comparative evaluation of immunotoxicity of DDT and its metabolites in rats. Indian J Exp Biol 1996; 34: 517-522.
37. Banerjee BD, Saha S, Mohapatra TK, Ray A. Influence of dietary protein on DDT-induced immune responsiveness in rats. Indian J Exp Biol 1995; 33: 739-744.
38. Rodgers K, Rodgers K. The immunotoxicity of pesticides in rodents Hum Exp Toxicol 1995; 14: 111-113.
39. Lahvis GP, Wells RS, Kuehl DW, Stewart JL, Rhinehart HL, Via CS. Decreased lymphocyte responses in free-ranging bottlenose dolphins (Tursiops truncatus) are associated with increased concentrations of PCBs and DDT in peripheral blood. Environ Health Perspect 1995; 103: 67-72.
40. Raszyk J, Toman M, Gajduskova V, Nezveda K, Ulrich R, Jarosova A, et al. Effects of environmental pollutants on the porcine and bovine immune systems. J Vet Med (Praha) 1997; 42: 313-317.
41. Rivedal E, Yamasaki H, Sanner T. Inhibition of gap junctional intercellular communication in Syrian hamster embryo cells by TPA, retinoic acid and DDT. Carcinogenesis 1994; 15: 689-694.
42. Wade MG, Foster WG, Younglai EV, McMahon A, Leingartner K, Yagminas A, et al. Effects of subchronic exposure to a complex mixture of persistent contaminants in male rats: systemic, immune, and reproductive effects. Toxicol Sci 2002; 67: 131-143.
43. Vine MF, Stein L, Weigle K, Schroeder J, Degnan D, Tse CK, et al. Effects on the immune system associated with living near a pesticide dump site. Environ Health Perspect 2000; 108: 1113-1124.
44. Lee TP, Moscati R, Park BH. Effects of pesticides on human leukocyte functions. Res Commun Chem Pathol Pharmacol 1979; 23: 597-609.
45. Kannan K, Sharma JD. Defective lymphocyte transformation by DDT: in vitro responsiveness of rabbit peripheral blood lymphocytes to PHA. Indian J Exp Biol 1979; 17: 805-806.
46. Tebourbi O, Rhouma KB, Sakly M. DDT induces apoptosis in rat thymocytes. Bull Environ Contam Toxicol 1998; 61: 216-223.
47. McMurray RW, Wilson JG, Bigler L, Xiang L, Lagoo A. Progesterone inhibits glucocorticoid-induced murine thymocyte apoptosis. Int J Immunopharmacol 2000; 22: 955-965.
48. Daniel V, Huber W, Bauer K, Suesal C, Conradt C, Opelz G. Associations of dichlorodiphenyltrichloroethane (DDT) 4.4 and dichlorodiphenyldichloroethylene (DDE) 4.4 blood levels with plasma IL-4. Arch Environ Health 2002; 57: 541-547.
49. Rehana T, Rao PR. Effect of DDT on the immune system in Swiss albino mice during adult and perinatal exposure: humoral responses. Bull Environ Contam Toxicol 1992; 48: 535-540.
50. Svensson BG, Hallberg T, Nilsson A, Schutz A, Hagmar L. Parameters of immunological competence in subjects with high consumption of fish contaminated with persistent organochlorine compounds. Int Arch Occup Environ Health 1994; 65: 351-358.
51. Sitarska E, Winnicka A, Klucinski W Zentralb L. Effects of organochlorine pesticides on the phagocytic activity of bovine milk cells. J Vet Med A. 1990; 37: 471-476.
52. Kaminski NE, Wells DS, Dauterman WC, Roberts JF, Guthrie FE. Macrophage uptake of a lipoprotein-sequestered toxicant: a potential route of immunotoxicity. Toxicol Appl Pharmacol 1986; 82: 474-480.
53. Nuñez G MA, Estrada I, Calderon-Aranda ES. DDT inhibits the functional activation of murine macrophages and decreases resistance to infection by Mycobacterium microti. Toxicol 2002; 174: 201-210.
54. Payne J, Rajapakse N, Wilkins M, Kortenkamp A. Prediction and assessment of the effects of mixtures of four xenoestrogens. Environ Health Perspect 2000; 108: 983-987.
55. Dunstan RH, Roberts TK, Donohoe M, McGregor NR, Hope D, Taylor WG, et al. Bioaccumulated chlorinated hydrocarbons and red/white blood cell parameters. Biochem Mol Med 1996; 58(1): 77-84.
56. Rosenberg AM, Semchuk KM, McDuffle HH, Ledingham DL, Cordeiro DM, Cessna AJ, et al. Prevalence of antinuclear antibodies in a rural population. J Toxicol Environ Health 1999; 57: 225-236.
57. Vineis P, D'Amore F. The role of occupational exposure and immunodeficiency in B-cell malignnancies. Working Group on the Epidemiology of Hematolymphopoietic Malignancies in Italy. Epidemiology 1992; 3: 266-270.
58. Calle EE, Frumkin H, Heneley SJ, Savitz DA, Thun MJ. Organochlorines and breast cancer risk. CA Cancer J Clin 2002; 52: 301-309.
59. Wright SC, Zhong J, Larrick JW. Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J 1994; 8: 654-660.
60. Liem AK, Furst P, Rappe C. Exposure of populations to dioxins and related compounds. Food Addit Contam 2000; 17: 241-259.
61. Huwe JK. Dioxins in food: a modern agricultural perspective. J Agric Food Chem 2002; 50: 1739-1750.
62. Okino ST, Whitlock JP Jr. The aromatic hydrocarbon receptor, transcription, and endocrine aspects of dioxin action. Vitam Horm 2000; 59: 241-264.
63. Ohtake F, Takeyama K, Matsumoto T, Kitagawa H, Yamamoto Y, Nohara K, et al. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor. Nature 2003; 423(6939): 545-550.
64. Hossain A, Tsuchiya S, Minegishi M, Osada M, Ikawa S, Tezuka FA, et al. The Ah receptor is not involved in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated apoptosis in human leukemic T cell lines. J Biol Chem 1998; 273: 19853-19858.
65. Vorderstrasse BA, Steppan LB, Silverstone AE, Kerkvliet NI. Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicol Appl Pharmacol 2001; 171: 157-164.
66. Beato, M. Gene regulation by hormones. Cell 1990; 56: 335-375.
67. Tsai M, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily member. Annu Rev Biochem 1994; 63: 451-486.
68. Sutherland, RL, Hamilton, JA, Sweeney, KJE, Watts, CK, Musgrove, EA. Steroidal regulation of the cell cycle. Ciba Foundation Symposium 1995; 191: 218.
69. Jellinck PH, Forkert PG, Riddick DS, Okey AB, Michnovicz JJ, Bradlow HL. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem Pharmacol 1993; 45: 1129-1136.
70. Jones MK, Weisenburger WP, Sipes IG, Russell DH. Circadian alterations in prolactin, corticosterone, and thyroid hormone levels and down regulation of prolactin receptor activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 1987; 87(2): 337-350.
71. Lu YF, Sun G, Wang X, Safe S. Inhibition of prolactin receptor gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 human breast cancer cells. Arch Biochem Biophys 1996; 332: 35-40.
72. Johnson E, Shorter C, Bestervelt L, Patterson D, Needham L, Piper W, et al. Serum hormone levels in humans with low serum concentrations of 2,3, 7,8-TCDD. Toxicol Ind Health 2001; 17: 105-112.
73. Mounho BJ, Davila DR, Burchiel SW. Characterization of intracellular calcium responses produced by polycyclic aromatic hydrocarbons in surface marker-defined human peripheral blood mononuclear cells. Toxicol Appl Pharmacol 1997; 145: 323-330.
74. Karras JG, Morris DL, Matulka RA, Kramer CM, Holsapple MP. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion. Toxicol Appl Pharmacol 1996; 137: 275-284.
75. Karras JG, Holsapple MP. Inhibition of calcium-dependent B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 1994; 125: 264-270.
76. Tian Y, Rabson AB, Gallo MA. Ah receptor and NF-kappaB interactions: mechanisms and physiological implications. Chem Biol Interact 2002; 141: 97-115.
77. Sulentic CE, Holsapple MP, Kaminski NE. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. J Pharmacol Exp Therap 2000; 295: 705-716.
78. Ruby CE, Leid M, Kerkvliet NI. 2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses tumor necrosis factor-alpha and anti-CD40-induced activation of NF-kappaB/Rel in dendritic cells: p50 homodimer activation is not affected. Mol Pharmacol 2002; 62: 722-728.
79. Bruno ME, Borchers CH, Dial JM, Walker NJ, Hartis JE, Wetmore BA, et al. Effects of TCDD upon IkappaB and IKK subunits localized in microsomes by proteomics. Arch Biochem Biophys 2002; 406: 153-164.
80. Suh J, Jeon YJ, Kim HM, Kang JS, Kaminski NE, Yang KH. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells. Toxicol Appl Pharmacol 2002; 181: 116-123.
81. Jeon MS, Esser C. The murine IL-2 promoter contains distal regulatory elements responsive to the Ah receptor, a member of the evolutionarily conserved bHLH-PAS transcription factor family. J Immunol 2000; 165: 6975-6983.
82. Snyder NK, Kramer CM, Dooley RK, Holsapple MP. Characterization of protein phosphorylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in murine lymphocytes: indirect evidence for a role in the suppression of humoral immunity. Drug Chem Toxicol 1993; 16: 135-163.
83. Clark GC, Blank JA, Germolec DR, Luster MI. 2,3,7,8-Tetrachlorodibenzo-p-dioxin stimulation of tyrosine phosphorylation in B lymphocytes: potential role in immunosuppression. Mol Pharmacol 1991; 39(4): 495-501.
84. Enan E, Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induced alterations in protein phosphorylation in guinea pig adipose tissue. J Biochem Toxicol 1993; 8: 89-99.
85. Lawrence BP, Kerkvliet NI. Role of altered arachidonic acid metabolism in 2,3,7, 8-tetrachlorodibenzo-p-dioxin-induced immune suppression in C57Bl/6 mice. Toxicol Sci 1998; 42: 13-22.
86. Vogel C, Schuhmacher US, Degen GH, Goebel C, Abel J. Differential effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the expression of prostaglandin-H synthase isoenzymes in mouse tissues. Adv Exp Med Biol 1997; 433: 139-143.
87. Vorderstrasse BA, Kerkvliet NI. 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects the number and function of murine splenic dendritic cells and their expression of accessory molecules. Toxicol Appl Pharmacol 2001; 171: 117-125.
88. Svensson C, Silverstone AE, Lai ZW, Lundberg K. Dioxin-induced adseverin expression in the mouse thymus is strictly regulated and dependent on the aryl hydrocarbon receptor. Biochem Biophys Res Commun 2002; 291: 1194-1200.
89. McMurray RW, Suwaanaroj S, Ndebele K, Jenkins J. Differential effects of sex steroids on T and B cells: modulation of cell cycle phase distribution, apoptosis, and bcl-2. Pathobiology 2001; 69: 44-58.
90. Crawford RB, Sulentic CE, Yoo BS, Kaminski NE. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation and post-translational modification of p27kiP1 in lipopolysaccharide-activated B Cells. Toxicol Sci 2003; 25.
91. Dietrich C, Faust D, Budt S, Moskwa M, Kunz A, Bock KW, Oesch F. 2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: involvement of cyclin A. Toxicol Appl Pharmacol 2002; 183: 117-126.
92. Lai ZW, Fiore NC, Hahn PJ, Gasiewicz TA, Silverstone AE. Differential effects of diethylstilbestrol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on thymocyte differentiation, proliferation, and apoptosis in bcl-2 transgenic mouse fetal thymus organ culture. Toxicol Appl Pharmacol 2000; 168: 15-24.
93. Roy D, Palangat M, Chen CW, Thomas RD, Colerangle J, Atkinson A, Yan ZJ. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals. J Toxicol Environ Health 1997; 50: 1-29.
94. Staples JE, Fiore NC, Frazier DE Jr, Gasiewicz TA, Silverstone AE. Overexpression of the antiapoptotic oncogene, bcl-2, in the thymus does not prevent thymic atrophy induced by estradiol or 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 1998; 151: 200-210.
95. Yang AL, Smith AG, Akhtar R, Clothier B, Robinson S, MacFarlane M, Festing MF. Low levels of p53 are associated with resistance to tetrachlorodibenzo-p-dioxin toxicity in DBA/2 mice. Pharmacogenetics 1999; 9: 183-188.
96. Bagchi D, Balmoori J, Bagchi M, Ye X, Williams CB, Stohs SJ. Role of p53 tumor suppressor gene in the toxicity of TCDD, endrin, naphthalene, and chromium (VI) in liver and brain tissues of mice. Free Radic Biol Med 2000; 8: 895-903.
97. Riecke K, Schmidt A, Stahlmann R. Effects of 2,3,7,8-TCDD and PCB 126 on human thymic epithelial cells in vitro. Arch Toxicol 2003; 77: 358-364.
98. Vorderstrasse BA, Dearstyne EA, Kerkvliet NI. Influence of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the antigen-presenting activity of dendritic cells. Toxicol Sci 2003; 72: 103-112.
99. Laiosa MD, Lai ZW, Thurmond TS, Fiore NC, DeRossi C, Holdener BC, et al. 2,3,7,8-tetrachlorodibenzo-p-dioxin causes alterations in lymphocyte development and thymic atrophy in hemopoietic chimeras generated from mice deficient in ARNT2. Toxicol Sci 2002; 69: 117-124.
100. Tsukumo S, Iwata M, Tohyama C, Nohara K. Skewed differentiation of thymocytes toward CD8 T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires activation of the extracellular signal-related kinase pathway. Arch Toxicol 2002; 76: 335-343.
101. Pryputniewicz SJ, Nagarkatti M, Nagarkatti PS. Differential induction of apoptosis in activated and resting T cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and its repercussion on T cell responsiveness. Toxicology 1998; 129: 211-226.
102. Nohara K, Ushio H, Tsukumo S, Kobayashi T, Kijima M, Tohyama C, Fujimaki H. Alterations of thymocyte development, thymic emigrants and peripheral T cell population in rats exposed to 2,3, 7,8-tetrachlorodibenzo-p-dioxin Toxicology 2000; 145: 227-235.
103. Dearstyne EA, Kerkvliet NI. Mechanism of 2,3, 7,8-tetrachlotodibenzo-p-dioxin (TCDD)-induced decrease in anti-CD3-activated CD4(+) T cells: the roles of apoptosis, Fas, and TNF. Toxicology 2002; 170: 139-151.
104. Camacho IA, Nagarkatti M, Nagarkatti PS. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces Fas-dependent activation-induced cell death in superantigen-primed T cells. Arch Toxicol 2002; 76: 570-580.
105. Camacho IA, Hassuneh MR, Nagarkatti M, Nagarkatti PS. Enhanced activation-induced cell death as a mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced immunotoxicity in peripheral T cells. Toxicology 2001; 165: 51-63.
106. Silverstone AE, Frazier DE Jr, Fiore NC, Soults JA, Gasiewicz TA. Dexamethasone, beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets. Toxicol Appl Pharmacol 1994; 126: 248-259.
107. Quadri SA, Qadri AN, Hahn ME, Mann KK, Sherr DH. The bioflavonoid galangin blocks aryl hydrocarbon receptor activation and polycyclic aromatic hydrocarbon-induced pre-B cell apoptosis Mol Pharmacol 2000; 58: 515-525.
108. Thurmond TS, Gasiewicz TA. A single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin produces a time-and dose-dependent alteration in the murine bone marrow B-lymphocyte maturation profile. Toxicol Sci 2000; 58: 88-95.
109. Prell RA, Dearstyne E, Steppan LG, Vella AT, Kerkvliet NI. CTL hyporesponsiveness induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin: role of cytokines and apoptosis. Toxicol Appl Pharmacol 2000; 166: 214-221.
110. Ho-Jun K, Kang BN, Cho SW, Son HY, Jeong KS, Park SJ, et al. Effects of benzo[a]pyrene, 2-bromopropane, phenol and 2,3,7,8-tetrachlorodibenzo-p-dioxin on proinflammatory cytokines gene expression by mice spleen cells. J Vet Sci 2002; 3: 247-254.
111. Lundberg K, Dencker L, Gronvik KO. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits the activation of antigen-specific T-cells in mice. Int J Immunopharmacol 1992; 14: 699-705.
112. Prell RA, Oughton JA, Kerkvliet NI. Effect of 2,3, 7,8-tetrachlorodibenzo-p-dioxin on anti-CD3-induced changes in T-cell subsets and cytokine production. Int J Immunopharmacol 1995; 17: 951-961.
113. Ito T, Inouye K, Fujimaki H, Tohyama C, Nohara K. Mechanism of TCDD-induced suppression of antibody production: effect on T cell-derived cytokine production in the primary immune reaction of mice. Toxicol Sci 2002; 70: 46-54.
114. Nohara K, Fujimaki H, Tsukumo S, Inouye K, Sone H, Tohyama C. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on T cell-derived cytokine production in ovalbumin (OVA)-immunized C57Bl/6 mice Toxicol 2002; 172: 49-58.
115. Lai ZW, Hundeiker C, Gleichmann E, Esser C. Cytokine gene expression during ontogeny in murine thymus on activation of the aryl hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmacol 1997; 52: 30-37.
116. Rier SE, Coe CL, Lemieux AM, Martin DC, Morris R, Lucier GW, Clark GC. Increased tumor necrosis factor-alpha production by peripheral blood leukocytes from TCDD-exposed rhesus monkeys. Toxicol Sci 2001; 60: 327-337.
117. Fan F, Yan B, Wood G, Viluksela M, Rozman KK. Cytokines (IL-1beta and TNF-alpha) in relation to biochemical and immunological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicol 1997; 116: 9-16.
118. Buchanan DL, Ohsako S, Tohyama C, Cooke PS, Iguchi T. Dioxin inhibition of estrogen-induced mouse uterine epithelial mitogenesis involves changes in cyclin and transforming growth factor-beta expression. Toxicol Sci 2002; 66: 62-68.
119. Sugita-Konishi Y, Kobayashi K, Naito H, Miura K, Suzuki Y. Effect of lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on the susceptibility to Listeria infection. Biosci Biotechnol Biochem 2003; 67: 89-93.
120. Vorderstrasse BA, Bohn AA, Lawrence BP. Examining the relationship between impaired host resistance and altered immune function in mice treated with TCDD. Toxicol 2003; 188: 15-28.
121. Fujimaki H, Nohara K, Kobayashi T, Suzuki K, Eguchi-Kasai K, Tsukumo S, et al. Effect of a single oral dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin on immune function in male NC/Nga mice. Toxicol Sci 2002; 66: 117-124.
122. Suh J, Kang JS, Yang KH, Kaminski NE. Antagonism of aryl hydrocarbon receptor-dependent induction of CYP1A1 and inhibition of IgM expression by di-ortho-substituted polychlorinated biphenyls. Toxicol Appl Pharmacol 2003; 187: 11-21.
123. Inouye K, Ito T, Fujimaki H, Takahashi Y, Takemori T, Pan X, et al. Suppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the high-affinity antibody response in C57BL/6 Mice Toxicol Sci 2003; 74: 315-324.
124. Suh J, Kang JS, Yang KH, Kaminski NE. Antagonism of aryl hydrocarbon receptor-dependent induction of CYP1A1 and inhibition of IgM expression by di-ortho-substituted polychlorinated biphenyls. Toxicol Appl Pharmacol 2003; 187: 11-21.
125. Lang DS, Becker S, Clark GC, Devlin RB, Koren HS. Lack of direct immunosuppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human peripheral blood lymphocyte subsets in vitro. Arch Toxicol 1994; 68: 296-302.
126. Neubert R, Jacob-Muller U, Helge H, Stahlmann R, Neubert D. Polyhalogenated dibenzo-p-dioxins and dibenzofurans and the immune system. 2-In vitro effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on lymphocytes of venous blood from man and non-human primate (Callithrix jacchus). Arch Toxicol 1991; 65: 213-219.
127. Watanabe S, Kitamura K, Nagahashi M. Effects of dioxins on human health: a review. J Epidemiol 1999; 9: 1-13.
128. Pesatori AC, Zocchetti C, Guercilena S, Consonni D, Turrini D, Bertazzi PA. Dioxin exposure and non-malignant health effects: a mortality study. Occup Environ Med 1998; 55: 126-131.
129. Bertazzi PA, Consonni D, Bachetti S, Rubagotti M, Baccarelli A, Zocchetti C, Pesatori AC. Health effects of dioxin exposure: a 20-year mortality study. Am J Epidemiol 2001; 153: 1031-1044.
130. Baccarelli A, Mocarelli P, Patterson DG Jr, Bonzini M, Pesatori AC, Caporaso N, Landi MT. Immunologic effects of dioxin: new results from Seveso and comparison with other studies. Environ Health Perspect 2002; 110: 1169-1173.
131. Kitamura K, Kikuchi Y, Watanabe S, Waechter G, Sakurai H, Takada TJ. Health effects of chronic exposure to polychlorinated dibenzo-p-dioxins (PCDD), dibenzofurans (PCDF) and coplanar PCB (Co-PCB) of municipal waste incinerator workers Epidemiol. 2000; 10: 262-270. Erratum in: J Epidemiol 2000; 10: 361.
132. Kitamura K, Kikuchi Y, Watanabe S, Waechter G, Sakurai H, Takada TJ. Health effects of chronic exposure to polychlorinated dibenzo-p-dioxins (PCDD), dibenzofurans (PCDF) and coplanar PCB (Co-PCB) of municipal waste incinerator workers Epidemiol. 2000; 10: 262-270. Erratum in: J Epidemiol 2000; 10: 361.
133. Feeley M, Brouwer A. Health risks to infants from exposure to PCBs, PCDDs and PCDFs. Food Addit Contam 2000; 17: 325-333.
134. Halperin W, Vogt R, Sweeney MH, Shopp G, Fingerhut M, Petersen M. Immunological markers among workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Occup Environ Med 1998; 55: 742-749.
135. Holladay SD. Prenatal immunotoxicant exposure and postnatal, autoimmune disease. Environ Health Perspect 1999; 107: 687-691.
136. Tonn T, Esser C, Schneider EM, Steinmann-Steiner-Haldenstatt W, Gleichmann E. Persistence of decreased T-helper cell function in industrial workers 20 years after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Environ Health Perspect 1996; 104: 422-426.
137. Zober A, Ott MG, Fleig I, Heidemann A. Cytogenetic studies in lymphocytes of workers exposed to 2,3,7,8-TCDD. Int Arch Occup Environ Health 1993; 65: 157-161.
138. Nagayama J, Nagayama M, Iida T, Hirakawa H, Matsueda T, Ohki M, Tsuji H. Effects of donor age and contamination level of dioxins and related chemicals on frequency of sister chromatid exchanges in human lymphocytes cultured in vitro. Chemosphere 2001; 43: 845.
139. The World Bank Group. Available on line at http://www.worldbank.org/depweb/beyond/beyondbw/begbw_08.pd